2[2]Ramsay J,Ward R,Bleehen NM. Radiosensitivity testing of human malignant gliomas[J]. Int J Radiat Oncol Biol Phys, 1992,24(4) :675.
3[3]Price P,McMillan TJ.Use of the tetrazolium assay in measuring the response of human tumor cells to ionizing radiation[J ]. Cancer Res, 1990,50(5) : 1392.
4[4]Thames HD,Withers HR,Mason KA,et al. Dose-suvival characteristics of mouse jejurial crypt cells[J ]. Int J Radiat Oncol Biol Phys,1981,7(11):1591.
5[5]Perez CA,Brady LW. Principles and practice of radiation oncology[M]. Lippincott Raven Publishers, 1998:92.
6[6]Tribius S,Pidel A,Casper D. ATM protein expression correlates with radioresistance in primary glioblastoma cells in culture [J ].Int J Radiat Oncol Biol Phys,2001,50(2) :511.
7[7]Pekkola-Heino K, Servomaa K, Kiuru A, et al. Increased radiosensitivity is associated with p53 mutations in cell lines derived from oral cavity carcinoma [J]. Acta Otolaryngol Stockh,1996,116(2) :341.
8[8]Fertil B,Malaise EP. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors:analysis of 101 published survival curves [J ]. Int J Radiat Oncol Biol Phys, 1985,11(9): 1699.
9[9]Malaise EP,Fertil B,Deschavanne PJ,et al. Initial slope of radiation survival curves is characteristic of the origin of primary and established cultures of human tumor cells and fibroblasts[J]. Radiat Res, 1987,111(2) :319.
10[10]Gaussen A, Legal JD, Beron Gaillard N, et al. Radiosensitivity of human normal and tumoral thyroid cells using fluorescence in sim hybridization and clonogenic survival assay[J ]. Int J Radiat Oncol Biol Phys, 1999,44(3) :683.
二级参考文献5
1Lee A W，Int J Radiat Oncol Biol Phys，1999年，44卷，1期，149页
5Rodel F, Hoffmann J, Distel L, et al. Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. Cancer Res, 2005, 65: 4481-4487.
6Lu B, Mu Y, Cao C, et al.Survivin as a therapeutic target for radiation sensitization in lung cancer. Cancer Res, 2004, 64:2840-2845.
7Rosa J, Canovas P, Islam A, et al. Survivin modulates microtubule dynamics and nucleation throughout the cell cycle. Mol Biol Cell, 2006, 17: 1483-1493.
8Altieri DC. Targeted therapy by disabling crossroad signaling networks: the survivin paradigm. Mol Cancer Ther, 2006, 5: 478- 482.
9Tribius S, Pidel A, Casper D, et al. ATM protein expression correlates with radioresistance in primary glioblastoma cells in culture. Int J Radiation Oncology Biol Phys ,2001,50:511-523.
10Taghian A, Ramsay J, Allalunis-Turner J, et al. Intrinsic radiation sen- sitivity may not be the major determinant of the poor clinical outcome of glioblastoma muhiforme. Int J Radiat Oncol Biol Phys, 1993,25: 243 -249.
